Draft guidance on management of rolling reviews for drug submissions: Performance targets and standards, cancellation

Name: Draft guidance on management of rolling reviews for drug submissions: Performance targets and standards, cancellation
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

The time to complete the screening of a drug submission with a rolling review is 25 days. Once the screening acceptance letter is issued, the review 1 period would begin. The submission would immediately be placed on “rolling review” until Health Canada receives all of the missing information, as indicated in the notice.

Publisher: Health Canada
Resources: 2
Catalogue metadata updated: 2023-09-01

Data overview

Formats: HTML
File languages: English, French

Official sources and licences

Government of Canada Open Data
Open Government Licence – Canada

Resources

Draft guidance on management of rolling reviews for drug submissions: Performance targets and standards, cancellation (French, HTML) HTML
Draft guidance on management of rolling reviews for drug submissions: Performance targets and standards, cancellation (English, HTML) HTML

Related open data

Health Canada